1. Inhibits TLK1 kinase activity by 60%. 2. Inhibits cellular TLK1 by reduced phosphorylation levels of pRad9 at 5 µM. 3. Cytotoxic towards Prostate cancer and Glioblastoma. LNCaP- 3.8µM DU145-19.1 µM LN227-14.1 µM 4. Suppresses colony formation ability of LNCaP cells when administered along with Bicalutamide.